Matthew Falagas MD, MSc, DSc

BOOKS

1. Falagas ME, Mylonakis E (editors). Gorbach’s 5-Minute Infectious Diseases Consult (textbook), 2^nd edition. Lippincott, Williams &Wilkins, Philadephia, Pensylvania, 2012.
2. Gorbach SL, Falagas ME (editors). 5-Minute Infectious Diseases Consult (textbook), 1^st edition. Lippincott, Williams &Wilkins, Philadephia, Pensylvania, 2001.
3. Gorbach SL, Bartlett JG, Falagas ME, Hamer D. Guidelines for Infectious Diseases in   Primary Care (handbook). Lippincott Williams and Wilkins, Philadelphia, Pensylvania, 1999.

BOOK CHAPTERS

1. FalagasME, Karveli
2. Siempos II, FalagasME. Impact of passive immunization in ventilated patients. Esquinas R (ed), Esquinas Pub., Murcia, Spain (in press).
3. Pappas G, Falagas ME. Urethritis and dysuria. In: Schlossberg D (ed). Clinical infectious disease (3^rd edition), Cambridge, UK (in press).
4. Vardakas KZ, Samonis G, FalagasME. Meta-analyses in the field of neutropenic fever. In: Akova M, et al (ed). Infectious complications of neutropenic patients (in press).
5. FalagasME, Makris G. Mesh related infections after hernia repair. In: Schumpelic V, Fitzgibbons RJ (ed). Complications of hernia repair (in press). 
6. Falagas ME, Bliziotis I. Fundamentals of antibiotics. In: Ross J (ed). The Principles and Practice of Hospital Medicine . McGraw Hill (in press).
7. Vergidis P, Falagas ME. Control of multi-drug resistant acinetobacter infections. In: Gould IM, van der Meer JWM (ed). Antibiotic policies. Springer, Germany, 2011
8. Vardakas KZ, Samonis G, Falagas ME. Decrasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials. In: Akova M, Akan H (ed). Febril Notropeni. Bilimsel Tip Yayineni, Ankara, 2010.
9. Rafailidis PI, FalagasME. Ampicillin-sulbactam. In: Grayson L, et al (ed). Kucers’ use of antibiotics. Hodder Arnold, London,UK, 2010.
10. Vergidis PI, FalagasME. Sulbactam. In: Grayson L, et al (ed). Kucers’ use of antibiotics. Hodder Arnold, London,UK, 2010.
11. Michalopoulos A, FalagasME. Acinetobacter infections. In: Vincent JL, Hall JB (ed). Encyclopedia of intensive care medicine . Springer, Germany (in preparation).
12. Falagas ME, Apostolou K. Mechanisms of inflammation in the intervertebral disc. In: Sapkas E (ed). Diseases of Spine . Kafkas Co., Athens, Greece, 2006, pages 141-148.
13. Falagas ME, Choulis N, Michalopoulos A. Polymyxins. In: Yu V (ed). Antimicrobial therapy (2^nd electronic edition, www.antimicrobe.org). Apple Trees Productions, LCC, New York, New York, 2005.
14. Falagas ME, Kasiakou S. Emergency management of neutropenic patients with fever. In: Seitanidis B, Georgilis K (eds). Emergency management of infectious diseases . Beta Co., Athens, Greece, 2003, pages, 51-72.
15. Falagas ME.  Modern management of neutropenic patients with fever. In: Lymperatos K, et al (eds). Developments in internal medicine , Hygeia Hospital Publications, Athens, Greece, 2001, pages 327-346.
16. Snydman DR, Falagas ME. Infection control in solid organ-transplant recipients. In: Abrutyn E, Goldmann D, Scheckler WE (eds).  Saunders infection control reference service, 2^nd edition, W.B. Saunders Co., Philadelphia, Pennsylvania, 2001, pages 757-769.
17. Snydman DR, Falagas ME. Infection control in solid organ-transplant recipients. In: Abrutyn E, Goldmann D, Scheckler WE (eds).  Saunders infection control reference service, 1^st  edition, W.B. Saunders Co., Philadelphia, Pennsylvania, 1998, pages 631-636.
18. Falagas ME, Gorbach SL. Traveler’s diarrhea. In: LaMont TJ (ed). Gastrointestinal  infections: diagnosis and management , Marcel Dekker Inc., New York, 1997, pages 125-148.

ABSTRACTS

(selection of abstracts from international scientific meetings)

1. Theocharis G, Mavros MN, Vouloumanou EK, Peppas G, Barbas SG, Spiropoulos T, Falagas ME. Comparison of morbidity of elderly in August and November in Attica, Greece: a prospective study. 10^th Congress of the European Federation of Internal Medicine, October 2011, Athens, Greece.
2. Theocharis G, Vouloumanou EK, Kontopidis I, Barbas SG, Rodis D, Eusthathiadis M, Falagas ME.Outpatient parenteral antibiotic therapy (OPAT) in Attica, Greece. 10^th Congress of the European Federation of Internal Medicine, October 2011, Athens, Greece.
3. Theocharis G, Polyzos KA, Vouloumanou EK, Peppas G, Spiropoulos T, Barbas SG, Falagas ME. Morbidity of foreign travelers in Attica, Greece: a retrospective study. 10^th Congress of the European Federation of Internal Medicine, October 2011, Athens, Greece.
4. Samonis G, Koutsounaki E, Karageorgopoulos DE, Mitsikostas P, Kalpadaki C, Bozionelou V, Bobolaki I, Sgouros J, Taktikou V, Falagas ME. Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. 51st ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2011,Chicago, Illinois.
5. Samonis G, Maraki S, Vouloumanou EK, Georgantzi GG, Kofteridis DP, Falagas ME. Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance. 51st ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2011,Chicago, Illinois.
6. Makris MC, Polyzos KA,  Mavros MN, Athanasiou S, Rafailidis PI, Falagas ME. Safety of hepatitis B, pneumococcal, and meningococcal vaccines in pregnancy: evaluation of the published evidence. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
7. Mavros MN, Athanasiou S, Alexiou VG, Mitsikostas PK, Peppas G, Falagas ME. Risk factors for mesh-related infections after hernia repair surgery: an evaluation of the published evidence. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
8. Samonis G, Maraki S, Karageorgopoulos DE, Vouloumanou EK, Falagas ME. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against MDR Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
9. Kapaskelis AM, Karfopoulou AT, Karageorgopoulos DE, Falagas ME. Biofilm-associated eye infections: an evaluation for the published evidence. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
10. Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME. Boric acid for recurrent vulvovaginal candidiasis: The clinical evidence. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
11. Kakisi OK, Vouloumanou EK, Rafailidis PI, Falagas ME. Cost effectiveness of PCR versus culture for MRSA in hospitals: a systematic review. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
12. Karageorgopoulos DE, Qu JM, Korbila IP, ZhuYG, Vasileiou VA, Falagas ME. Accuracy of the β-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. 21^st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
13. Mantadakis E, Vouloumanou EK, Georgantzi GG, Tsalkidis A, Chatzimichael A, Falagas ME. Acute DMSA for Identifying Dilating VUR in Children with a First UTI: A Meta-analysis. 21^st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2011, Milan, Italy.
14. Alexiou VG, Michalopoulos A, Makris GC, Peppas G, Samonis G, Falagas ME. Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study. XIV Annual Conference of the European Surgical Society (ESS), November 2010, Turin, Italy.
15. Mavros MN, Gkegkes ID, Polyzos K, Peppas G, Falagas ME. Impact of psychological variables on early surgical recovery: a systematic review. XIV Annual Conference of the European Surgical Society (ESS), November 2010, Turin, Italy.
16. Gkegkes ID, Mavros MN, Alexiou VG, Peppas G, Athanasiou S, Falagas ME. Adhesive strips for the closure of surgical wounds: a systematic review and meta-analysis. XIV Annual Conference of the European Surgical Society (ESS), November 2010, Turin, Italy.
17. Hatziagelaki E, Karageorgopoulos DE, Chounta A, Tsiavou, Economopoulos T, Falagas ME. Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease. 4^6th EASD - Annual Meeting of the European Association for the Study of Diabetes, September 2010, Stockholm, Sweden.
18. Falagas ME, Thomaidis PC, Kotsantis KK, Sgouros K, Samonis G, Karageorgopoulos DE. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. 50th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2010,Boston, Massachusetts.
19. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. β-D-Glucan assay for the diagnosis of invasive fungal infections:

a meta-analysis. 50th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2010,Boston, Massachusetts.

1. Iavazzo C, Gkegkes ID, Vouloumanou EK, amais I. Peppas G, Falagas ME. Sutures versus staples for the management of surgical wounds: a meta-analysis of randomized controlled trials. 50th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2010,Boston, Massachusetts.
2. Falagas ME, Vouloumanou EK, Togias AG, KAradima M, Kapaskelis AM, Rafailidis PI, Athanasiou S. Fosfomycin versus other antibiotics for the treatment of cystitis:

a meta-analysis of randomized controlled trials. 50th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2010,Boston, Massachusetts.

1. Theocharis G, Vouloumanou EK, Rafailidis PI, Spiropoulos T, Barbas SG, Falagas ME. Evaluation of a direct test for seasonal influenza in outpatients. 13th ICEM - International Conference on Emergency Medicine , June 2010, Singapore, Singapore.
2. Falagas ME. Clinical Strategies to manage CRAB and PDR-PA in critically ill patients. 6^th Asia Pacific Infectious Disease Forum , June 2010, Tagaytay, Philippines.
3. Falagas ME, Vouloumanou EK, Plessa E, Peppas G, Rafailidis PI. Inaccuracies in dosing drugs with teaspoons-tablespoons. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , April 2010, Vienna, Austria.
4. Karageorgopoulos DE, Rafailidis PI, Kastoris AC, Kapaskelis AM, Falagas ME. Fosfomycin: the issue of emergence of antimicrobial resistance. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2010, Vienna, Austria.
5. Vardakas KZ, Mavros MN, Roussos N, Falagas ME. Vancomycin for the treatment of patients with Gram positive infections: a meta-analysis of randomized controlled trials. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2010, Vienna, Austria.
6. Falagas ME,Vouloumanou EK, Sgouros C, Athanasiou S, Peppas G, SiemposII. Patients included in randomized controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , April 2010, Vienna, Austria.
7. Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , April 2010, Vienna, Austria.
8. Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Kapaskelis A, Samonis G. Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , April 2010, Vienna, Austria.
9. Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , April 2010, Vienna, Austria.
10. Agrafiotis M, Siempos II, Ntaidou TK, Falagas ME. Attributable mortality of ventilator-associated pneumonia: a meta-analysis. 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2010, Vienna, Austria.
11. Vorgias G, Iavazzo C, Makarova E, Akrivos T, Falagas ME. Acinetobacter baumannii in a patient with endometrial carcinoma. 16^th International Meeting of the European Society of Gynaecological Oncology (ESGO), October 2009, Belgrade, Serbia.
12. Mantadakis E, Plessa E, Vouloumanou EK, Karageorgopoulos DE, Chatzimichael A, Falagas ME. Serum Procalcitonin for Prediction of Renal Parenchymal Involvement in Children with Urinary Tract Infections: A Meta-analysis of Prospective Clinical Studies. 49th ICAAC/ Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2009,San Francisco, CA.
13. Samonis G, Maraki S, Rafailidis PI, Kapaskelis A, Kastoris AC, Falagas ME. Antimicrobial susceptibility of Gram-negative non-urinary bacteria to fosfomycin and other antimicrobials. 49th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2009,San Francisco, CA.
14. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including ESBL-producing, Enterobacteriaceae infections: a systematic review of microbiological and clinical studies. 49th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2009,San Francisco, CA.
15. Michalopoulos A, Virtzili S, Rafailidis P, Halevelakis GH, Falagas ME. Intravenous fosfomycin for the treatment of nosocomial infections due to carbapenem-resistant Klebsiella pneumoniae in critically ill patients. A prospective evaluation. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
16. Rafailidis P, Kouranos V, Christodoulou C, Falagas ME. Linezolid for patients with neutropenia: can bacteriostatic agents be used in this patient population? 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
17. Bakossi A, Pitsouni E, Holevas P, Stamata E, Falagas ME. An analysis of isolation of Mycoplasma hominis and Ureoplasma urealyticum from genital tract speciments of women receiving care at a geneal hospital serving rural population in Greece. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
18. Kechagia A, Kakisi O, Kakisis I, Falagas ME. Tuberculosis in the oral cavity: a systematic review of the published evidence. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Filand.
19. Falagas ME, Kotsantis I, Vouloumanou E, Rafailidis P. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
20. Dandoulakis M, Roussos N, Karageorgopoulos DK, Yatromanolakis N, Falagas ME. Trends of tuberculin skin test positivity rate among children 6-14 years old in Attica, Greece. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
21. Varbobitis I, Pappas G, Karageorgopoulos DK, Anagnostopoulos I, Falagas ME. Cystic echinococcosis: decreasing prevalence in central Greece. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2009, Helsinki, Finland.
22. Siempos II, Vardakas KZ, Kyriakopoulos C, Ntaidou T, Falagas ME. Predictors of mortality in patients with ventilator-associated pneumonia: a meta-analysis. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
23. Falagas ME, Kastoris A, Vouloumanou EK, Dimopoulos G. Community-acquired Stenotrophomonas maltophilia infections: a systematic review. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
24. Falagas ME, Kouranos V, Michalopoulos A, Rodopoulou S, Athanasoulia A, Karageorgopoulos DK. Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences between the compared groups. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
25. Agrafiotis M, Siempos II, Falagas ME. Frequency, prevention, outcome, and treatment of ventilator associated tracheobrochitis: a systematic review and meta-analysis. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
26. Alexiou VG, Ierodiakonnou I, Peppas G, Falagas ME. NA Antimicrobial prophylaxis in surgery: an international survey. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
27. Korbila I, Michalopoulos A, Rafailidis P, Nikita D, Samonis G, Falagas ME. Inhaled colistin as adjunctice to intravenous colistin for the treatment of microbiologically documented VAP. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
28. Falagas ME, Karamanidou C, Karlis G, Kastoris A, Rafailidis P. The effect of psychological and psychosocial factors on the outcome of or susceptibility to acute respiratory tract infections. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
29. Vouloumanou EK, Karageorgopoulos DK, Kazantzi M, Kapaskelis A, Falagas ME. Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized contolled trials. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 2009, Helsinki, Finland.
30. Vardakas KZ, Matthaiou DK, Falagas ME. Comparison of clinical features and mortality risk associated with pneumonia due to community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus productivity the Panton-Valentine leukocidin. 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , May 2009, Helsinki, Finland.
31. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A. Colistin therapy for multidrug-resistant Gram (-) bacterial infections: A study of 258 patients. 11^th Western Pacific Congress on Chemotherapy and Infectious Diseases (WPCCID) , Taipei, Taiwan, November 2008.
32. Pappas G, Ierodiakonou V, Falagas ME. Lost in translation: Different antimicrobial licensing policies in US and Europe. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) / 46^th Infectious Diseases Society of America (IDSA) Annual Meeting, Washington DC, October 2008.
33. Bakossi AS, Ntziora F, Karle PP, Karle AP, Cholevas PB, Petropoulou D, Falagas ME. Trends of antimicrobial resistance of blood isolates from patients in a public tertiary hospital in Greece. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
34. Vouloumanou EK, Rafailidis PI, Kazantzi MS, Falagas ME. Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
35. Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A. Inhaled colistin as monotherapy for multidrug-resistant gram-negative nosocomial pneumonia: a case series. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
36. Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME. Probiotics for the prevention of respiratory tract infections: a systematic review of the evidence from randomized controlled trials. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
37. Athanasoulia AP, Karageorgopoulos DE, Peppas G, Falagas ME. Effect of body mass index on the outcome of infections: A systematic review. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
38. Vardakas KZ, Matthaiou DK, Falagas ME. Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta-analysis of randomized controlled trials. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
39. Papadimitriou P, Pappas G, Kontogiannis KE, Falagas ME. A World Wide Web guide to pediatric infectious diseases. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
40. Karageorgopoulos DK, Valkimadi PE, Kapaskelis A, Rafailidis PI, Falagas ME. Short versus long duration antibiotic therapy for bacterial meningitis: A meta-analysis of randomized controlled trials. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
41. Falagas ME, Ierodiakonnou V, Alexiou VG. Clinical practice of obtaining blood cultures from patients with a central venous catheter (CVC) in place: an international survey. 48th ICAAC / 46^th IDSA Annual Meeting, Washington DC, October 2008.
42. Kondilis B, Akrivos PD, Salloum S, Falagas ME. Health literacy in Athens, Greece: Exploring sources of health information in adults. European Health Management Association Annual Conference. Athens, Greece, June 2008.
43. Falagas ME, Akrivos PD, Alexiou VG, Saridakis V, Moutos T, Peppas G, Kondilis B. Understanding informed consent: an Athenian sample of surgery patients. European Health Management Association Annual Conference . Athens, Greece, June 2008.
44. Pitsouni E, Alexiou VG, Saridakis V, Peppas G, Falagas ME. Does the use of probiotics/synbiotics in patients undergoing abdominal surgery prevent postoperative infections? A systematic review of randomised controlled trials. 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2008.
45. Athanassa Z, Siempos II, Falagas ME. Impact of methicillin-resistance on the mortality in S. aureus VAP: a systematic review. 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2008.
46. Falagas ME, Zarkadoulia E. Factors associated with suboptimal compliance to vaccinations. 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , April 2008.
47. Siempos II, Vardakas KZ, Falagas ME. Closed tracheal suction systems for prevention of ventilator-associated pneumonia. 18th ECCMID, Barcelona, Spain, April 2008.
48. Korbila I, Manta KG, Siempos II, Dimopoulos G, Falagas ME. Penicillins vs. trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: a meta-analysis of randomised controlled trials. 18th ECCMID, Barcelona, Spain, April 2008.
49. Matthaiou DK, Panos G, Adamidi E, Falagas ME. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. 18th ECCMID, Barcelona, Spain, April 2008.
50. Rafailidis PI, Matthaiou DK, Varbobitis I, Falagas ME. Use of ACE inhibitors and risk of community-acquired pneumonia. 18th ECCMID , Barcelona, Spain, April 2008.
51. Siempos II, Athanassa Z, Falagas ME. Frequency and predictors of ventilator-associated pneumonia recurrence: a meta-analysis. 18th ECCMID, Barcelona, Spain, April 2008.
52. Falagas ME, Makris GC, Matthaiou D, Rafailidis PI. Statins for infection and sepsis – A systematic review of the clinical evidence. 18th ECCMID , Barcelona, Spain, April 2008.
53. Falagas ME, Agrafiotis M, Athanassa Z, Siempos II. Administration of antibiotics via the respiratory tract as monotherapy for pneumonia. 18th ECCMID , Barcelona, Spain, April 2008.
54. Falagas ME, Vouloumanou EK, Matthaiou DK, Kapaskelis A, Karageorgopoulos D. Effectiveness and safety of short versus long duration of antibiotic therapy for group A streptococcal tonsillopharyngitis: a meta-analysis of randomised controlled trials. 18th ECCMID , Barcelona, Spain, April 2008.
55. Alexiou VG, Falagas ME. e-meducation.org: an open access medical education web portal focused on infectious diseases. 18th ECCMID, Barcelona, Spain, April 2008.
56. Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii infections: characteristics and outcomes in a series of 28 patients. 18th ECCMID , Barcelona, Spain, April 2008.
57. Vardakas KZ, Michalopoulos A, Kiriakidou K, Siampli E, Samonis G, Falagas ME. Candidaemia: incidence, risk factors, characteristics, and outcomes in immunocompetent critically ill patients. 18th ECCMID, Barcelona, Spain, April 2008.
58. Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos D, Papaioannou V, Ntani G, Samonis G, Falagas ME. Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: a matched case-control study. 18th ECCMID, Barcelona, Spain, April 2008.
59. Kyriakidou K, Rafailidis P, Athanassiou S, Matthaiou DK, Falagas ME. Short versus long course antibiotic therapy for acute pyelonephritis in adults: a meta-analysis of randomised controlled trials. 18th ECCMID, Barcelona, Spain, April 2008.
60. Falagas ME, Karageorgopoulos D, Grammatikos A, Matthaiou DK. Effectiveness and safety of short versus long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomised trials. 18th ECCMID , Barcelona, Spain, April 2008.
61. Karamanis E, Matthaiou DK, Moraitis L, Falagas ME. Fluoroquinolones versus beta-lactam-based regimens for the treatment of osteomyelitis: a meta-analysis of randomised controlled trials. 18th ECCMID, Barcelona, Spain, April 2008.
62. Falagas ME, Peppas G, Makris GC, Karageorgopoulos D, Matthaiou DK. Ertapenem for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials. 18th ECCMID , Barcelona, Spain, April 2008.
63. Karageorgopoulos D, Giannopoulou K, Grammatikos A, Dimopoulos G, Falagas ME. Fluoroquinolones versus beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomised controlled trials. 18th ECCMID, Barcelona, Spain, April 2008.
64. Falagas ME, Giannopoulou K, Vardakas KZ, Dimopoulos G, Karageorgopoulos D. Comparison of antibiotics with placebo for the treatment of presumed acute bacterial sinusitis: a meta-analysis of randomised controlled trials. 18th ECCMID , Barcelona, Spain, April 2008.
65. Theocharis G, Peppas G, Spanos A, Vlara LA, Issaris EA, Panos G, Falagas ME. Effect of meteorological variables on the incidence of respiratory tract infections. 12th International Conference on Emergency Medicine (ICEM), San Francisco, California,  April 2008.
66. Falagas ME, Matthaiou DK, Karveli EA, Peppas G. Clindamycin/aminoglycoside versus beta-lactam monotherapy for the treatment of intra-abdominal infections: a meta-analysis of randomised controlled trials. 25^th International Congress of Chemotherpy (ICC)/17^th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), Munich, Germany, April 2007.
67. Falagas ME, Pitsouni E, Bliziotis IA. Temporal trends in the methodological quality of randomised controlled trials of antimicrobial agents. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
68. Dimopoulos G, Siempos II, Korbila I., Manta KG, Falagas ME. Comparison of first with second-line antibiotics for acute bacterial exacerbations of chronic bronchitis: a meta-analysis of randomised controlled trials. 25^th ICC / 17th ECCMID, Munich, Germany, April 2007.
69. Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. A meta-analysis of risk factors for mortality in patients with emphysematous pyelonephritis. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
70. Falagas ME, Polemis M, Alexiou VG, Sarantou I, Kremastinou J, Vatopoulos AC. Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
71. Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans bloodstream infection in critically ill patients: differences in risk factors and outcome. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
72. Falagas ME, Siempos II, Vardakas KZ. Linezolid versus a glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: a meta-analysis of randomised controlled trials. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
73. Falagas ME, Mourtzoukou EG, Ntziora F, Peppas G, Rafailidis PI. Matching criteria in case-control studies in postoperative infections. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
74. Rafailidis PI, Kakisi OK, Vardakas KZ, Falagas ME. Infectious complications of monoclonal antibodies used in cancer therapy. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
75. Falagas ME, Mourtzoukou EG, Giannopoulou K, Alexiou VG, Rafailidis PI. Matching criteria in case-control studies in the field of antimicrobial resistance. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
76. Falagas ME, Siempos II, Korbila IP, Manta KG, Dimopoulos G. Comparison of macrolides, quinolones, and amoxicillin/clavulanic acid for the treatment of patients with acute bacterial exacerbations of chronic bronchitis: a meta-analysis of randomised controlled trials. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
77. Panos G, Xirouchakis E, Tzias V, Charatsis G, Bliziotis IA, Doulgeroglou V, Margetis N, Falagas ME. Helicobacter pylori infection in symptomatic HIV-seropositive and seronegative patients: a case-control study. 25^th ICC / 17th ECCMID, Munich, Germany, April 2007.
78. Falagas ME, Bliziotis II, Rafailidis PI. Do high doses of quinolones decrease the emergence of antibacterial resistance? A systematic review of data from comparative clinical trials. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
79. Panos G, Charatsis G, Paparizos V, Kazantzi M, Falagas ME. Prevalence of genotypic resistance to nucleoside analogues, non-nucleoside analogues and protease inhibitors in HIV-infected persons in Athens, Greece. 25^th ICC / 17th ECCMID, Munich, Germany, April 2007.
80. Falagas ME, Karveli EA, Siempos II, Vardakas KZ. Acinetobacter infections: a growing threat for critically ill patients. 25^th ICC / 17th ECCMID , Munich, Germany, April 2007.
81. Kondilis B, Kiriaze I, Falagas ME. Mapping European research on health literature. 7^th International Conference on Health Promotion and Patient Education, Budapest, Hungary, November 2006.
82. Falagas ME, Kazantzi MA, Bliziotis IA. Comparison of clinical utility of blood cultures obtained from intravascular catheters and peripheral veins: a systematic review of the available evidence. 46^th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, September 2006.
83. Falagas ME, Fragoulis KN, Bliziotis IA. Oral rifampin for prevention of S. aureus carriage related infections in patients with renal failure: a meta-analysis of randomized controlled trials. 46^th ICAAC, San Francisco, California, September 2006.
84. Matthaiou DK, Peppas G, Bliziotis IA, FalagasME. Ciprofloxacin/metronidazole versus beta-lactam based treatment of intra-abdominal infections: a meta-analysis of comparative trials. 46^th ICAAC, San Francisco, California, September 2006.
85. Falagas ME, Matthaiou DK, Vardakas KZ.  Fluoroquinolones versus β-lactams for the empirical treatment of immunocompetent patients with skin and soft tissue infections: a meta-analysis of randomized controlled trials. 46^th ICAAC, San Francisco, California, September 2006.
86. VardakasKZ, HorianopoulouM, FalagasME. Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials. 46^th ICAAC, San Francisco, California, September 2006.
87. FalagasME, RafailidisPI, Kasiakou SK, HatzopoulouP, MichalopoulosEffectiveness and nephrotoxicity of colistin monotherapy versus colistin/meropenem combination therapy for multidrug-resistant gram negative bacterial infections. 46^th ICAAC, San Francisco, California, September 2006.
88. Mavrogenis AF, Zahos KA, Paliobeis C, Bliziotis IA, FalagasME, Papagelopoulos PJ. Spondylodiscitis after facet joint steroid infection. 25^thAnnual Meeting of the European Bone and Joint Infection Society Meeting , Budapest, Hungary, May 2006.
89. Kasiakou S, Lawrence K, Choulis N, Falagas ME. Continuous versus intermittent intravenous administration of antibiotics with time-dependent anti-bacterial action: a systematic review of pharmacokinetic and pharmacodynamic parameters.16^th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Nice, France, April 2006.        
90. Horianopoulou M, Legakis N, Kanellopoulou M, Lambropoulos S, Tsakris A, Falagas ME. Frequency and predictors of colonisation of the respiratory tract by Gram-negative bacteria with the blaVIM gene in patients of a newly established intensive care unit. 16^th ECCMID,Nice, France, April 2006.        
91. Falagas ME, Siempos I, Bliziotis I, Rellos K, Michalopoulos A. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. 16^th ECCMID ,Nice, France, April 2006.        
92. Rafailidis P, Kasiakou S, Morfou P, Georgoulias G, Nikita D, Falagas ME. Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital.16^th ECCMID,Nice, France, April 2006.        
93. Falagas ME, Fragoulis K, Bliziotis I, Chatzinikolaou I. Rifampin and minocycline impregnated central venous catheters: a meta-analysis of randomised controlled trials assessing catheter colonisation and catheter-related bloodstream infection.16^th ECCMID ,Nice, France, April 2006.
94. Kopterides P, Koletsi P, Morfou P, Rellos K, Mastora Z, Rizos M, Falagas ME. Exposure to fluoroquinolones is a risk factor for polymyxin-only susceptible Acinetobacter baumannii bacteraemia. 16^th ECCMID,Nice, France, April 2006.
95. Koletsi P, Kopterides P, Michalopoulos A, Mastora Z, Rellos K, Falagas ME. Risk factors for polymyxin-only susceptible Pseudomonas aeruginosa bacteraemia. 16^th ECCMID,Nice, France, April 2006.
96. Falagas ME, Matthaiou D, Papastamataki P, Bliziotis I. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. 16^th ECCMID ,Nice, France, April 2006.
97. Falagas ME, Bliziotis I, Michalopoulos A, Sermaides G, Papaioannou V, Nikita D, Choulis N. Effect of a policy for restriction of selected classes of antibiotics on antimicrobial drug cost and resistance. 16^th ECCMID ,Nice, France, April 2006.
98. Falagas ME, Fragoulis K, Kasiakou S, Sermaides G, Michalopoulos A. Nephrotoxicity of intravenous colistin: a prospective evaluation. 16^th ECCMID ,Nice, France, April 2006.
99. Falagas ME, Karydis I, Georgoulias G, Hatzopoulou P, Nikita D, Kostogiannou I. Needlestick and sharp injuries of health care personnel in a newly founded tertiary hospital: a prospective study.16^th ECCMID ,Nice, France, April 2006.
100. Falagas ME, Fragoulis K, Zouglakis G, Karydis I. A comparative study on the cost of new drugs in different therapeutic categories. 16^th ECCMID ,Nice, France, April 2006.
     
     

     • Start
     • Prev
     • 3
     • 4
     • 5
     • 6
     • 7
     • 8
     • 9
     • 10
     • 11
     • 12
     • Next
     • End